Resveratrol Analogs Ameliorate Mitochondrial Impairment and Insulin Resistance in a Streptozotocin-Induced In Vitro Model of Alzheimer’s Disease
International Journal of Molecular Sciences · 06.11.2025 · 26 (21) · 10787
DOI: 10.3390/ijms262110787 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.11.2025. Verfasst von Alexandra Paszternák und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics, Semmelweis University, 4 Nagyvárad tér, H-1089 Budapest, Hungary. Hauptthemen laut MEDLINE: Resveratrol, Insulin Resistance, Alzheimer Disease, Mitochondria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, National Research, Development and Innovation Fund, Semmelweis 250+ Excellence Ph.D. Scholarship.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is characterized by mitochondrial dysfunction, oxidative stress, insulin resistance, and aberrant protein aggregation. Neurodegeneration model with neuronal insulin resistance was induced in SH-SY5Y human neuroblastoma cells by streptozotocin (STZ). We evaluated the neuroprotective effects of resveratrol (RZV) and three structural analogs: oxyresveratrol (OXI), monomethyl resveratrol (MONO), and trimethyl resveratrol (TRI). Mitochondrial function, plasma membrane integrity, oxidative stress) and autophagy were studied by fluorescent assays. Phosphorylated GSK3 levels were measured by ELISA as an indicator of insulin sensitivity. TRI exhibited significant mitochondrial protective effects and strongly induced autophagy. OXI demonstrated excellent antioxidant activity but showed no detectable mitochondrial protective or autophagy-inducing effects. RZV and MONO exhibited moderate antioxidant effects along with strong insulin-sensitizing and autophagy-inducing properties. Insulin sensitivity was most potently restored by RZV (IC50 = 54 pM) and MONO (IC50 = 50 pM), whereas TRI (IC50 = 160 pM) was less potent, and OXI (IC50 = 97 pM) showed moderate potency. Our findings suggest that the neuroprotective effects of resveratrol analogs significantly depend on their molecular structure and that they exert their beneficial effects through distinct mechanisms. This research may contribute to the development of novel, multi-target compounds for the treatment of neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacodynamics, Semmelweis University, 4 Nagyvárad tér, H-1089 Budapest, Hungary.
- Center for Pharmacology and Drug Research & Development, Semmelweis University, 26 Üllői út, H-1085 Budapest, Hungary.
ORCID-Profile: Kamilla Varga, Katinka Tarnóczi, Éva Szökő, Tamás Tábi
Förderung
- National Research, Development and Innovation Office
- National Research, Development and Innovation Fund
- Semmelweis 250+ Excellence Ph.D. Scholarship
- Ruprecht Karls University
Zitieren
APA
Paszternák, A., Varga, K., Gyöngyössy, R., Tarnóczi, K., Sikur, N., Szökő, É., & Tábi, T. (2025). Resveratrol Analogs Ameliorate Mitochondrial Impairment and Insulin Resistance in a Streptozotocin-Induced In Vitro Model of Alzheimer’s Disease. International Journal of Molecular Sciences, 26(21), 10787. https://doi.org/10.3390/ijms262110787
Vancouver
Paszternák A, Varga K, Gyöngyössy R, Tarnóczi K, Sikur N, Szökő É, et al. Resveratrol Analogs Ameliorate Mitochondrial Impairment and Insulin Resistance in a Streptozotocin-Induced In Vitro Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 2025;26(21):10787. doi:10.3390/ijms262110787
BibTeX
@article{Paszternk2025,
author = {Paszternák, Alexandra and Varga, Kamilla and Gyöngyössy, Ramá and Tarnóczi, Katinka and Sikur, Noémi and Szökő, Éva and Tábi, Tamás},
title = {Resveratrol Analogs Ameliorate Mitochondrial Impairment and Insulin Resistance in a Streptozotocin-Induced In Vitro Model of Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10787},
doi = {10.3390/ijms262110787}
}
EUVIMED